ADORA

Structural and Functional Studies of Human Adenosine A2A Receptor G protein Complex: Toward Understanding GPCR Activation

 Coordinatore OULUN YLIOPISTO 

 Organization address address: Pentti Kaiteran Katu 1
city: OULU
postcode: 90014

contact info
Titolo: Dr.
Nome: Leila
Cognome: Risteli
Email: send email
Telefono: -5533653
Fax: -4176

 Nazionalità Coordinatore Finland [FI]
 Totale costo 100˙000 €
 EC contributo 100˙000 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2009-RG
 Funding Scheme MC-IRG
 Anno di inizio 2009
 Periodo (anno-mese-giorno) 2009-10-01   -   2013-09-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    OULUN YLIOPISTO

 Organization address address: Pentti Kaiteran Katu 1
city: OULU
postcode: 90014

contact info
Titolo: Dr.
Nome: Leila
Cognome: Risteli
Email: send email
Telefono: -5533653
Fax: -4176

FI (OULU) coordinator 100˙000.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

subtype    bco    team    functional    structure    human    adenosine    cell    co    allosteric    receptors    receptor    oulu    facilities    modulation    structural    gpcrs    university    salary   

 Obiettivo del progetto (Objective)

'This application is to partially fund a junior research position at the Oulu Biocenter (BCO) and the Department of Biochemistry, University of Oulu, concerning structural determination of human adenosine receptor subtype selectivity and allosteric modulation. As a basis of this project, we recently determined the crystal structure of the human adenosine A2A receptor. By the research described in the research plan, we will accomplish one or more of following goals (2010-2014): To solve human adenosine A1, A2A, A2B and A3 structure complexes with subtype-selective ligands and co-factors. To study allosteric modulation of adenosine receptors. To study the functional/structural role of lipids those were co-crystallized in the initial A2A structure. To determine the structure of carboxy terminal domain(s) of human A2A receptor and further characterize its functional properties and interaction partners. To biophysically characterize the dynamic and conformational changes upon ligand/co-factor binding in the purified adenosine receptor those are important to the activation mechanism. The main goal is to establish an independent research team and equipments at the BCO. The team would be specialized on structural and functional studies of GPCRs. The BCO and the protein science facilities available at Oulu University provides excellent environment for the research proposed, with access to instruments and facilities needed for the proposed research. The major collaborators in this project include R.C.Stevens (the Scripps Research Institute, USA) and A. Ijzeman (University of Leiden, Netherlands). We will seek more collaboration nationally and internationally on GPCRs and biophysical characterization of the targets. With this application, partial salary of the PI is applied. The BCO is committed support a start up package for setting up a laboratory, an annual grant for materials and consumables and salary for two other project members for this proposal.'

Introduzione (Teaser)

Adenosine is important for the normal function of nerve cells, controlling cell proliferation, and as a signal of inflammation. Adenosine cell surface receptors called A2A play a critical role in facilitating such functions.

Altri progetti dello stesso programma (FP7-PEOPLE)

IMPACT (2014)

Improved Millets for Phosphate ACquisition and Transport

Read More  

MEDCOM (2015)

Medical Complicity: A New Normative Account and Its Implications for Three Study Cases

Read More  

UNIQUE PRECURSOR (2012)

"Concise Synthesis of Tricyclic Angularly Fused Natural Products via Controlled Cyclizations of a Common Key Precursor: Preparation of Alliacanes, Arteannuins, Pentalenolactones and Triquinanes"

Read More